PET/CT in the management of haematological malignancies, European Journal of Haematology, vol.90, issue.1, pp.369-80, 2008. ,
DOI : 10.1097/00003072-200410000-00010
Interim FDG-PET in Hodgkin lymphoma: a compass for a safe navigation in clinical trials?, Blood, vol.120, issue.25, pp.4913-4933, 2012. ,
DOI : 10.1182/blood-2012-03-403790
Lymphome de Hodgkin de l'adulte. EMC -Hématologie, pp.115-134, 2004. ,
Cancer incidence and mortality in France over the period, Rev Epidemiol Sante Publique, vol.51, issue.1, pp.3-30, 1978. ,
URL : https://hal.archives-ouvertes.fr/hal-00428273
Concordance for Hodgkin's Disease in Identical Twins Suggesting Genetic Susceptibility to the Young-Adult Form of the Disease, New England Journal of Medicine, vol.332, issue.7, pp.332-413, 1995. ,
DOI : 10.1056/NEJM199502163320701
Immunohistochemical detection of the Epstein-Barr virus-encoded latent membrane protein 2A in Hodgkin's disease and infectious mononucleosis, Blood, vol.90, issue.4, pp.1664-72, 1997. ,
Cerebellar relapse of Hodgkin lymphoma, Leukemia & Lymphoma, vol.2, issue.4, pp.659-62, 2009. ,
DOI : 10.1111/j.1365-2141.2008.06998.x
[Rectal Hodgkin's disease in a patient with HIV infection], Presse Med, issue.37, pp.22-1883, 1993. ,
Imaging in staging of malignant lymphoma: a systematic review, Blood, vol.111, issue.2, pp.504-520, 2008. ,
DOI : 10.1182/blood-2007-07-101899
Routine Bone Marrow Biopsy Has Little or No Therapeutic Consequence for Positron Emission Tomography/Computed Tomography???Staged Treatment-Naive Patients With Hodgkin Lymphoma, Journal of Clinical Oncology, vol.30, issue.36, pp.30-4508, 2012. ,
DOI : 10.1200/JCO.2012.42.4036
F FDG-PET/CT in the detection of bone marrow disease in Hodgkin's lymphoma, The British Journal of Radiology, vol.85, issue.1016, pp.85-490, 1016. ,
DOI : 10.1259/bjr/29583493
Report of a committee convened to discuss the evaluation and staging of patients with Hodgkin's disease: Cotswolds meeting Toward comprehensive management tailored to prognostic factors of patients with clinical stages I and II in Hodgkin's disease. The EORTC Lymphoma Group controlled clinical trials, J Clin Oncol Blood, vol.7, issue.111, pp.1964-1987, 1989. ,
Hodgkin Lymphoma in Patients with HIV Infection: A Review, Current Hematologic Malignancy Reports, vol.50, issue.4, pp.228-262, 2012. ,
DOI : 10.1007/s11899-012-0125-2
Hodgkin Lymphoma in HIV Positive Patients, Current HIV Research, vol.8, issue.2, pp.141-147, 2010. ,
DOI : 10.2174/157016210790442704
Plasma Cytokine and Soluble Receptor Signature Predicts Outcome of Patients With Classical Hodgkin's Lymphoma: A Study From the Groupe d'Etude des Lymphomes de l'Adulte, Journal of Clinical Oncology, vol.25, issue.13, pp.25-1732, 2007. ,
DOI : 10.1200/JCO.2006.08.1331
A Prognostic Score for Advanced Hodgkin's Disease, New England Journal of Medicine, vol.339, issue.21 ,
DOI : 10.1056/NEJM199811193392104
The predictive value of positron emission tomography scanning performed after two courses of standard therapy on treatment outcome in advanced stage Hodgkin's disease, Haematologica, vol.91, issue.4, pp.475-81, 2006. ,
Treatment of Hodgkin's disease: Results and current concepts of the German Hodgkin's Lymphoma Study Group, Annals of Oncology, vol.11, issue.suppl 1, pp.81-86, 2000. ,
DOI : 10.1093/annonc/11.suppl_1.S81
Escalated-Dose BEACOPP in the Treatment of Patients With Advanced-Stage Hodgkin's Lymphoma: 10 Years of Follow-Up of the GHSG HD9 Study, Journal of Clinical Oncology, vol.27, issue.27, pp.27-4548, 2009. ,
DOI : 10.1200/JCO.2008.19.8820
Impact of 18F-Fluoro-2-Deoxyglucose Positron Emission Tomography on Treatment Strategy and Radiotherapy Planning for Stage I???II Hodgkin Disease: A Prospective Multicenter Study, International Journal of Radiation Oncology*Biology*Physics, vol.79, issue.3, pp.79-823, 2011. ,
DOI : 10.1016/j.ijrobp.2009.11.048
Early-Stage Hodgkin's Lymphoma, New England Journal of Medicine, vol.363, issue.7, pp.653-62, 2010. ,
DOI : 10.1056/NEJMra1003733
Chemotherapy plus Involved-Field Radiation in Early-Stage Hodgkin's Disease, New England Journal of Medicine, vol.357, issue.19 ,
DOI : 10.1056/NEJMoa064601
[Particularities of Hodgkin's lymphoma], Rev Prat, vol.60, issue.1, pp.75-84, 2010. ,
Revised Response Criteria for Malignant Lymphoma, Journal of Clinical Oncology, vol.25, issue.5, pp.579-86, 2007. ,
DOI : 10.1200/JCO.2006.09.2403
Principe et technique de la tomographie d'??mission de positons coupl??e ?? la tomodensitom??trie, EMC -Radiologie et Imagerie Médicale : Principes et techniques -Radioprotection, pp.35-310, 2010. ,
DOI : 10.1016/S1879-8497(10)72881-8
Impact of FDG-PET/CT in the management of lymphoma, Annals of Nuclear Medicine, vol.23, issue.Suppl. 5, pp.701-717, 2011. ,
DOI : 10.1007/s12149-011-0549-0
Standardised uptake value of 18F-FDG on staging PET/CT in newly diagnosed patients with different subtypes of non-Hodgkin???s lymphoma, European Journal of Haematology, vol.50, issue.1, pp.32-37, 2011. ,
DOI : 10.1111/j.1600-0609.2010.01532.x
High SUV uptake on FDG-PET/CT predicts for an aggressive B-cell lymphoma in a prospective study of primary FDG-PET/CT staging in lymphoma, Annals of Oncology, vol.20, issue.9, pp.1543-1550, 2009. ,
DOI : 10.1093/annonc/mdp030
Contribution of PET imaging to the initial staging and prognosis of patients with Hodgkin's disease, Annals of Oncology, vol.15, issue.11, pp.15-1699, 2004. ,
DOI : 10.1093/annonc/mdh426
Positron emission tomography in the staging of patients with Hodgkin???s lymphoma. A prospective multicentric study by the Intergruppo Italiano Linfomi, Annals of Hematology, vol.25, issue.Suppl 1, pp.86-897, 2007. ,
DOI : 10.1007/s00277-007-0356-9
Role of Functional Imaging in the Management of Lymphoma, Journal of Clinical Oncology, vol.29, issue.14, pp.1844-54, 2011. ,
DOI : 10.1200/JCO.2010.32.5225
Limitations of Applying Summary Results of Clinical Trials to Individual Patients, JAMA, vol.298, issue.10, pp.298-1209, 2007. ,
DOI : 10.1001/jama.298.10.1209
PET scan integration in lymphoma management, International Journal of Hematologic Oncology, vol.2, issue.2, pp.121-135, 2013. ,
DOI : 10.2217/ijh.13.11
Reduced Treatment Intensity in Patients with Early-Stage Hodgkin's Lymphoma, New England Journal of Medicine, vol.363, issue.7, pp.640-52, 2010. ,
DOI : 10.1056/NEJMoa1000067
FDG-PET after two cycles of chemotherapy predicts treatment failure and progression-free survival in Hodgkin lymphoma, Blood, vol.107, issue.1, pp.52-61, 2006. ,
DOI : 10.1182/blood-2005-06-2252
Prognostic value of interim FDG-PET after two or three cycles of chemotherapy in Hodgkin lymphoma, Annals of Oncology, vol.16, issue.7, pp.16-1160, 2005. ,
DOI : 10.1093/annonc/mdi200
Prognostic significance of mid- and post-ABVD PET imaging in Hodgkin's lymphoma: the importance of involved-field radiotherapy, Annals of Oncology, vol.20, issue.11, pp.20-1848, 2009. ,
DOI : 10.1093/annonc/mdp071
Pettengl R Results of the 3rd planned interim analysis of the UK NCRI RAPID Trial (Involved field radiotherapy versus no further treatment) in patients with clinical stage IA/IIA Hodgkin Lymphoma and a " negative " 18FDG- PET scan after 3 cycles of ABVD, 2011. ,
F]Fluoro-2-Deoxy-D-Glucose Positron Emission Tomography Is Prognostically Superior to International Prognostic Score in Advanced-Stage Hodgkin's Lymphoma: A Report From a Joint Italian-Danish Study, Journal of Clinical Oncology, vol.25, issue.24, pp.25-3746, 2007. ,
DOI : 10.1200/JCO.2007.11.6525
Report of satellite workshop on interim-PET in Hodgkin lymphoma, 8th International Symposium on Hodgkin Lymphoma, 2010. ,
Multicentre Clinical Study with early treatment intensification in high-risk Hodgkin Lymphoma (HL) patients with a positive FDG- PET scan after two ABVD courses ? GITIL HD0607 study, 2011. ,
Report on the First International Workshop on interim-PET scan in lymphoma, Leukemia & Lymphoma, vol.50, issue.8, pp.50-1257, 2009. ,
DOI : 10.1007/s00259-008-0787-0
18F-FDG PET for Posttherapy Assessment of Hodgkin's Disease and Aggressive Non-Hodgkin's Lymphoma: A Systematic Review, Journal of Nuclear Medicine, vol.49, issue.1, pp.13-21, 2008. ,
DOI : 10.2967/jnumed.107.039867
Use of Positron Emission Tomography for Response Assessment of Lymphoma: Consensus of the Imaging Subcommittee of International Harmonization Project in Lymphoma, Journal of Clinical Oncology, vol.25, issue.5, pp.571-579, 2007. ,
DOI : 10.1200/JCO.2006.08.2305
Cost Effectiveness of Positron Emission Tomography in Patients With Hodgkin's Lymphoma in Unconfirmed Complete Remission or Partial Remission After First-Line Therapy, Journal of Clinical Oncology, vol.28, issue.8, pp.28-1415, 2010. ,
DOI : 10.1200/JCO.2009.25.4367
18F-fluoro-deoxyglucose positron emission tomography for posttreatment evaluation of malignant lymphoma: a systematic review, Haematologica, vol.91, issue.4, pp.522-531, 2006. ,
Reduced-intensity chemotherapy and PET-guided radiotherapy in patients with advanced stage Hodgkin's lymphoma (HD15 trial): a randomised, open-label ,
Dimension of Residual CT Scan Mass in Hodgkin's Lymphoma (HL) Is a Negative Prognostic Factor in Patients with PET Negative After Chemo+/- Radiotherapy, 2011. ,
End-of-treatment but not interim PET scan predicts outcome in nonbulky limited-stage Hodgkin's lymphoma, Annals of Oncology, vol.22, issue.4, pp.910-915, 2011. ,
DOI : 10.1093/annonc/mdq549
Prognostic significance of mid- and post-ABVD PET imaging in Hodgkin's lymphoma: the importance of involved-field radiotherapy, Annals of Oncology, vol.20, issue.11, pp.20-1848, 2009. ,
DOI : 10.1093/annonc/mdp071
F]Fluorodeoxyglucose Positron Emission Tomography in Pediatric Hodgkin's Lymphoma: Analysis of a Prospective Multicenter Trial, Journal of Clinical Oncology, vol.27, issue.26, pp.27-4385, 2009. ,
DOI : 10.1200/JCO.2008.19.7814
Postchemotherapy PET evaluation correlates with patient outcome in paediatric Hodgkin???s disease, European Journal of Nuclear Medicine and Molecular Imaging, vol.37, issue.3, pp.1620-1627, 2011. ,
DOI : 10.1007/s00259-011-1836-7
Report of an International Workshop to Standardize Response Criteria for Non-Hodgkin's Lymphomas, Journal of Clinical Oncology, vol.17, issue.4, p.1244, 1999. ,
DOI : 10.1200/JCO.1999.17.4.1244
Concordance between four European centres of PET reporting criteria designed for use in multicentre trials in Hodgkin lymphoma, European Journal of Nuclear Medicine and Molecular Imaging, vol.17, issue.10, pp.37-1824, 2010. ,
DOI : 10.1007/s00259-010-1490-5
Report on the Third International Workshop on Interim Positron Emission Tomography in Lymphoma and Menton 2011 consensus, Leuk Lymphoma, issue.10, pp.26-27, 2011. ,
Interim positron emission tomography scan in Hodgkin lymphoma: definitions, interpretation rules, and clinical validation, Leukemia & Lymphoma, vol.17, issue.2, pp.50-1761, 2009. ,
DOI : 10.1200/JCO.2009.22.4089
Report on the Second International Workshop on interim positron emission tomography in lymphoma, Leuk Lymphoma, issue.12, pp.51-2171, 2010. ,
International Validation Study for Interim PET in ABVD-Treated ,
An international confirmatory study of the prognostic value of early PET/CT in diffuse large B-cell lymphoma: comparison between Deauville criteria and ??SUVmax, European Journal of Nuclear Medicine and Molecular Imaging, vol.119, issue.Suppl 1, 2013. ,
DOI : 10.1007/s00259-013-2435-6
Relationship Between Cancer Type and Impact of PET and PET/CT on Intended Management: Findings of the National Oncologic PET Registry, Journal of Nuclear Medicine, vol.49, issue.12, pp.49-1928, 2008. ,
DOI : 10.2967/jnumed.108.056713
Use of Dual-Point Fluorodeoxyglucose Imaging to Enhance Sensitivity and Specificity, Seminars in Nuclear Medicine, vol.42, issue.4, pp.267-80, 2012. ,
DOI : 10.1053/j.semnuclmed.2012.02.003
FDG Accumulation and Tumor Biology, Nuclear Medicine and Biology, vol.25, issue.4, pp.317-339, 1998. ,
DOI : 10.1016/S0969-8051(97)00226-6
Dual time point 18F-FDG PET imaging for differentiating malignant from inflammatory processes, J Nucl Med, vol.42, issue.9, pp.1412-1419, 2001. ,
FDG PET of Infection and Inflammation, RadioGraphics, vol.25, issue.5, pp.1357-68, 2005. ,
DOI : 10.1148/rg.255045122
Hybrid imaging systems in the diagnosis of osteomyelitis and prosthetic joint infection, Q J Nucl Med Mol Imaging, vol.53, issue.1, pp.95-104, 2009. ,
High accumulation of fluorine-18-fluorodeoxyglucose in turpentine-induced inflammatory tissue, J Nucl Med, vol.36, issue.7, pp.1301-1307, 1995. ,
Increased (18)F-fluorodeoxyglucose uptake in benign, nonphysiologic lesions found on whole-body positron emission tomography/computed tomography (PET/CT): accumulated data from four years of experience with PET/CT, Semin Nucl Med, issue.3, pp.37-206, 2007. ,
Whole body [(18) F]fluorodeoxyglucose positron emission tomography imaging for the diagnosis of pacemaker or implantable cardioverter defibrillator infection: a preliminary prospective study, Clin Microbiol Infect, issue.6, pp.17-836, 2011. ,
Advantage of delayed whole-body FDG-PET imaging for tumour detection, European Journal of Nuclear Medicine, vol.28, issue.6 ,
DOI : 10.1007/s002590100537
Relationship between retention index in dual-phase (18)F-FDG PET, and hexokinase-II and glucose transporter-1 expression in pancreatic cancer, J Nucl Med, vol.43, issue.2, pp.173-80, 2002. ,
FDG-PET in oncology: there's more to it than looking at pictures, J Nucl Med, vol.34, issue.1, pp.6-11, 1993. ,
The dose uptake ratio as an index of glucose metabolism: useful parameter or oversimplification?, J Nucl Med, issue.8, pp.35-1308, 1994. ,
A PET study of 18 FDG uptake in soft tissue masses, European Journal of Nuclear Medicine and Molecular Imaging, vol.26, issue.1, pp.22-30, 1999. ,
DOI : 10.1007/s002590050355
Optimal scan time for fluorine-18 fluorodeoxyglucose positron emission tomography in breast cancer, European Journal of Nuclear Medicine and Molecular Imaging, vol.26, issue.3, pp.226-256, 1999. ,
DOI : 10.1007/s002590050381
Dual time point fluorine-18 fluorodeoxyglucose positron emission tomography: a potential method to differentiate malignancy from inflammation and normal tissue in the head and neck, European Journal of Nuclear Medicine, vol.26, issue.10, pp.26-1345, 1999. ,
DOI : 10.1007/s002590050593
Dual time point 18F-FDG PET for the evaluation of pulmonary nodules, J Nucl Med, issue.7, pp.43-871, 2002. ,
Impact of dual-time-point 18F-FDG PET imaging and partial volume correction in the assessment of solitary pulmonary nodules, European Journal of Nuclear Medicine and Molecular Imaging, vol.39, issue.suppl, pp.246-52, 2008. ,
DOI : 10.1007/s00259-007-0584-1
Accuratezza della FDG PET-TC in fase precoce e in fase tardiva e della TC con mezzo di contrasto nella valutazione dei noduli polmonari: uno studio preliminare su 30 pazienti, La radiologia medica, vol.47, issue.6, pp.890-906, 2009. ,
DOI : 10.1007/s11547-009-0400-z
F-FDG PET in the Diagnosis of Pulmonary Nodules with an Initial Standard Uptake Value Less Than 2.5, American Journal of Roentgenology, vol.191, issue.2, pp.475-484, 2008. ,
DOI : 10.2214/AJR.07.3457
Diagnostic Performance of Dual-time 18F-FDG PET in the Diagnosis of Pulmonary Nodules: A Meta-analysis, Academic Radiology, vol.19, issue.2, pp.153-161, 2012. ,
DOI : 10.1016/j.acra.2011.10.009
single time point 18FDG-PET/CT for the differential diagnosis of pulmonary nodules: a meta-analysis, Acta Radiologica, vol.21, issue.7, 2013. ,
DOI : 10.1177/0284185113481594
Evaluation of Dual-Time-Point 18F-FDG PET for Staging in Patients with Lung Cancer, Journal of Nuclear Medicine, vol.49, issue.10, pp.49-1606, 2008. ,
DOI : 10.2967/jnumed.108.051250
Dual-Time-Point F-18 FDG PET/CT for Evaluation of Intrathoracic Lymph Nodes in Patients With Non-Small Cell Lung Cancer, Clinical Nuclear Medicine, vol.34, issue.4, pp.216-237, 2009. ,
DOI : 10.1097/RLU.0b013e31819a1f3d
Limited Predictive Value of Dual-Time-Point F-18 FDG PET/CT for Evaluation of Pathologic N1 Status in NSCLC Patients, Clinical Nuclear Medicine, vol.36, issue.6, pp.36-434, 2011. ,
DOI : 10.1097/RLU.0b013e31820adef8
Prognostic Implication of Dual-Phase PET in Adenocarcinoma of the Lung, Journal of Nuclear Medicine, vol.51, issue.4, pp.535-577, 2010. ,
DOI : 10.2967/jnumed.109.068643
Potential of dual-time-point imaging to improve breast cancer diagnosis with (18)F-FDG PET, J Nucl Med, issue.11, pp.46-1819, 2005. ,
Dual time point 18F-FDG PET imaging detects breast cancer with high sensitivity and correlates well with histologic subtypes, J Nucl Med, issue.9, pp.47-1440, 2006. ,
The value of dual-time-point 18F-FDG PET/CT for identifying axillary lymph node metastasis in breast cancer patients, Br J Radiol, pp.84-593, 1003. ,
Dual???Time-Point FDG PET/CT for the Evaluation of Pediatric Tumors, American Journal of Roentgenology, vol.200, issue.2, pp.408-421, 2013. ,
DOI : 10.2214/AJR.12.8930
Limited diagnostic and predictive values of dual-time-point 18F FDG PET/CT for differentiation of incidentally detected thyroid nodules, Annals of Nuclear Medicine, vol.29, issue.5, pp.347-53, 2011. ,
DOI : 10.1007/s12149-011-0468-0
Prognostic value of dual-time-point 18F-FDG PET-CT imaging in patients with head and neck squamous cell carcinoma, Nuclear Medicine Communications, vol.34, issue.6, pp.34-551, 2013. ,
DOI : 10.1097/MNM.0b013e32836089ab
URL : https://hal.archives-ouvertes.fr/hal-00831504
FDG uptake in brown adipose tissue???A brief report on brown fat with FDG uptake mechanisms and quantitative analysis using dual-time-point FDG PET/CT, Revista Espa??ola de Medicina Nuclear, vol.30, issue.1, pp.14-22, 2011. ,
DOI : 10.1016/j.remn.2010.05.006
Normal variants of bowel FDG uptake in dual-time-point PET/CT imaging, Annals of Nuclear Medicine, vol.35, issue.3 ,
DOI : 10.1007/s12149-010-0439-x
Dual time-point FDG PET-CT for differentiating benign from malignant solitary pulmonary nodules in a TB endemic area Prognostic value of dual-time-point 18F-fluorodeoxyglucose positron emission tomography in patients with pulmonary sarcoidosis, S Afr Med J Respirology, vol.100, issue.164, pp.713-733, 2010. ,
Dual-time-point F-18 FDG PET/CT for evaluation in patients with malignant lymphoma, Annals of Nuclear Medicine, vol.23, issue.8, pp.26-616, 2012. ,
DOI : 10.1007/s12149-012-0619-y
Dual-time-point F-18 FDG PET/CT imaging for differentiating the lymph nodes between malignant lymphoma and benign lesions, Annals of Nuclear Medicine, vol.26, issue.2, pp.163-172, 2013. ,
DOI : 10.1007/s12149-012-0669-1
Differentiation of Normal Thymus from Anterior Mediastinal Lymphoma and Lymphoma Recurrence at Pediatric PET/CT, Radiology, vol.262, issue.2, pp.613-635, 2012. ,
DOI : 10.1148/radiol.11110715
Detection and Characterization of Tumor Changes in 18F-FDG PET Patient Monitoring Using Parametric Imaging, Journal of Nuclear Medicine, vol.52, issue.3, pp.354-61, 2011. ,
DOI : 10.2967/jnumed.110.080150
SUV: standard uptake or silly useless value?, J Nucl Med, vol.36, issue.10, pp.1836-1845, 1995. ,
Partial-Volume Effect in PET Tumor Imaging, Journal of Nuclear Medicine, vol.48, issue.6, pp.932-977, 2007. ,
DOI : 10.2967/jnumed.106.035774
Respiratory Motion in Positron Emission Tomography/Computed Tomography: A Review, Seminars in Nuclear Medicine, vol.38, issue.3, pp.167-76, 2008. ,
DOI : 10.1053/j.semnuclmed.2008.01.002
Model-based respiratory motion compensation for emission tomography image reconstruction, Physics in Medicine and Biology, vol.52, issue.12, pp.3579-600, 2007. ,
DOI : 10.1088/0031-9155/52/12/016
URL : https://hal.archives-ouvertes.fr/inria-00616030